Lantheus Medical Imaging Receives Performance Award from Premier Purchasing Partners, L.P.

June 12, 2008 at 2:46 PM EDT

N. Billerica, MASSACHUSETTS (June 12, 2008) – Lantheus Medical Imaging, a worldwide leader in diagnostic imaging, today announced that the company has received a Purchasing Partners' Supplier Performance Award from Premier Purchasing Partners, L.P., the nation's largest healthcare Group Purchasing Organization (GPO), for outstanding performance in quality and compliance as a contracted Premier supplier.  The award was presented at Premier’s Annual Breakthroughs Conference and Exhibition held in Nashville, TN on June 11, 2008.

Lantheus Medical Imaging is one of 54 of more than 800 Premier contracted suppliers to receive the Performance Award, which recognizes the efforts of contracted suppliers to meet or exceed Premier members’ service expectations.  Based on performance data collected during the year and shared with contracted suppliers through Premier’s supplier quality and business line review process, the annual awards are designed to align contracted supplier performance to meet or exceed Premier’s and its members’ expectations on a consistent basis.

“This award speaks to our unwavering commitment to our customers and, ultimately, to the patients we serve,” said Don Kiepert, President and CEO of Lantheus Medical Imaging.  “We are honored to be recognized by Premier and look forward to continuing the relationship we’ve established over our three-year partnership.”

About Lantheus Medical Imaging
Lantheus Medical Imaging, a worldwide leader in diagnostic medicine for the past 50 years, is committed to elevating and investing in the field of diagnostic imaging. The company’s proven success in discovering, developing and marketing innovative medical imaging agents provides an unparalleled platform from which to bring forward breakthrough new tools for the diagnosis and management of disease. The company is home to leading diagnostic imaging brands, including Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), DEFINITY® Vial For (Perflutren Lipid Microsphere) Injectable Suspension, and TechneLite® (Technetium Tc99m Generator) and has nearly 700 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada, and Australia.  For more information, visit
www.lantheus.com.

About Premier Inc., 2006 Malcolm Baldrige National Quality Award recipient
Serving more than 2,000 U.S. hospitals and 50,000 other healthcare sites, the Premier healthcare alliance and its members are transforming healthcare together. Owned by not-for-profit hospitals, Premier operates one of the leading healthcare purchasing networks and the nation's most comprehensive repository of hospital clinical and financial information. A subsidiary operates one of the nation's largest policy-holder owned, hospital professional liability risk-retention groups. A world leader in helping healthcare providers deliver dramatic improvements in care, Premier is working with the United Kingdom's National Health Service North West and the Centers for Medicare & Medicaid Services to improve hospital performance. Headquartered in San Diego, Premier has offices in Charlotte, N.C., Philadelphia and Washington. For more information, visit
www.premierinc.com.
###